Balaji Gandhi Sells 975 Shares of Phreesia (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 975 shares of the firm’s stock in a transaction dated Thursday, January 15th. The stock was sold at an average price of $16.38, for a total value of $15,970.50. Following the completion of the transaction, the chief financial officer owned 155,256 shares of the company’s stock, valued at approximately $2,543,093.28. This represents a 0.62% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Balaji Gandhi also recently made the following trade(s):

• On Friday, January 16th, Balaji Gandhi sold 4,687 shares of Phreesia stock. The shares were sold at an average price of $16.36, for a total value of $76,679.32.
• On Thursday, January 8th, Balaji Gandhi sold 8,009 shares of Phreesia stock. The stock was sold at an average price of $17.01, for a total transaction of $136,233.09.

Phreesia Price Performance

NYSE:PHR traded down $0.63 during mid-day trading on Tuesday, hitting $15.76. 888,246 shares of the stock traded hands, compared to its average volume of 1,011,187. The business’s 50-day moving average price is $18.24 and its 200 day moving average price is $23.18. The company has a market cap of $950.23 million, a PE ratio of -157.59 and a beta of 0.61. Phreesia, Inc. has a 12-month low of $15.41 and a 12-month high of $32.76. The company has a quick ratio of 2.44, a current ratio of 2.44 and a debt-to-equity ratio of 0.01.

Phreesia (NYSE:PHR) last posted its earnings results on Monday, December 8th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.11. The business had revenue of $120.33 million for the quarter, compared to analysts’ expectations of $119.98 million. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The business’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.25) EPS. On average, analysts expect that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have weighed in on PHR shares. Barclays decreased their target price on Phreesia from $26.00 to $24.00 and set an “overweight” rating on the stock in a research note on Tuesday, December 16th. Truist Financial set a $24.00 price objective on shares of Phreesia in a research report on Thursday, January 8th. KeyCorp lowered their target price on shares of Phreesia from $35.00 to $32.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 8th. Needham & Company LLC reissued a “buy” rating and issued a $35.00 price target on shares of Phreesia in a research note on Monday, December 8th. Finally, Robert W. Baird decreased their price target on shares of Phreesia from $31.00 to $25.00 and set an “outperform” rating on the stock in a report on Wednesday, December 10th. Seventeen research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Phreesia presently has a consensus rating of “Moderate Buy” and an average target price of $30.06.

Institutional Investors Weigh In On Phreesia

A number of institutional investors have recently made changes to their positions in the business. Royal Bank of Canada grew its holdings in shares of Phreesia by 208.8% during the 1st quarter. Royal Bank of Canada now owns 24,119 shares of the company’s stock valued at $617,000 after purchasing an additional 16,309 shares during the last quarter. AQR Capital Management LLC boosted its position in Phreesia by 471.2% during the first quarter. AQR Capital Management LLC now owns 160,032 shares of the company’s stock valued at $4,090,000 after buying an additional 132,015 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Phreesia by 3.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 62,557 shares of the company’s stock valued at $1,599,000 after buying an additional 2,158 shares during the last quarter. NewEdge Advisors LLC increased its holdings in shares of Phreesia by 262.7% in the first quarter. NewEdge Advisors LLC now owns 15,437 shares of the company’s stock worth $395,000 after buying an additional 11,181 shares during the period. Finally, Goldman Sachs Group Inc. lifted its stake in shares of Phreesia by 0.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 600,012 shares of the company’s stock valued at $15,336,000 after acquiring an additional 2,402 shares during the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.